↓ Skip to main content

Trends in carbapenem resistance in Pre-COVID and COVID times in a tertiary care hospital in North India

Overview of attention for article published in Annals of Clinical Microbiology and Antimicrobials, January 2023
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trends in carbapenem resistance in Pre-COVID and COVID times in a tertiary care hospital in North India
Published in
Annals of Clinical Microbiology and Antimicrobials, January 2023
DOI 10.1186/s12941-022-00549-9
Pubmed ID
Authors

Nirupama Chatterjee, Pushpa K. Nirwan, Shruti Srivastava, Ruchi Rati, Lalit Sharma, Priyanka Sharma, Priyambada Dwivedi, Namita Jaggi

Abstract

Carbapenem resistance is endemic in the Indian sub-continent. In this study, carbapenem resistance rates and the prevalence of different carbapenemases were determined in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa during two periods; Pre-COVID (August to October 2019) and COVID (January to February 2021) in a north-Indian tertiary care hospital. Details of patient demographics and clinical condition was collated from the Hospital Information System and detection of carbapenemases NDM, OXA-48, VIM, IMP and KPC was done by Polymerase chain reaction (PCR) in 152 and 138 non-consecutive carbapenem resistant isolates during the two study periods respectively. Conjugation assay and sequencing of NDM and OXA-48 gene was done on a few selected isolates. As compared to Pre-COVID period, co-morbidities and the mortality rates were higher in patients harbouring carbapenem resistant organisms during the COVID period. The overall carbapenem resistance rate for all the four organisms increased from 23 to 41% between the two periods of study; with Pseudomonas aeruginosa and Klebsiella pneumoniae showing significant increase (p < 0.05). OXA-48, NDM and co-expression of NDM and OXA-48 were the most common genotypes detected. NDM-5 and OXA-232 were most common variants of NDM and OXA-48 family respectively during both the study periods. Higher rate of carbapenem resistance in COVID times could be attributed to increase in number of patients with co-morbidities. However, genetic elements of carbapenem resistance largely remained the same in the two time periods.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 7%
Student > Ph. D. Student 1 7%
Student > Bachelor 1 7%
Other 1 7%
Student > Master 1 7%
Other 0 0%
Unknown 10 67%
Readers by discipline Count As %
Unspecified 1 7%
Mathematics 1 7%
Biochemistry, Genetics and Molecular Biology 1 7%
Immunology and Microbiology 1 7%
Medicine and Dentistry 1 7%
Other 0 0%
Unknown 10 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2023.
All research outputs
#14,389,550
of 23,495,502 outputs
Outputs from Annals of Clinical Microbiology and Antimicrobials
#268
of 622 outputs
Outputs of similar age
#186,676
of 432,967 outputs
Outputs of similar age from Annals of Clinical Microbiology and Antimicrobials
#3
of 10 outputs
Altmetric has tracked 23,495,502 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 622 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,967 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.